Silibinin Restores NAD+ Levels and Induces the SIRT1/AMPK Pathway in Non-Alcoholic Fatty Liver
Published 2017 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Silibinin Restores NAD+ Levels and Induces the SIRT1/AMPK Pathway in Non-Alcoholic Fatty Liver
Authors
Keywords
-
Journal
Nutrients
Volume 9, Issue 10, Pages 1086
Publisher
MDPI AG
Online
2017-10-03
DOI
10.3390/nu9101086
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Targeting NAD + degradation: The therapeutic potential of flavonoids for Alzheimer's disease and cognitive frailty
- (2018) Qingwei Ruan et al. PHARMACOLOGICAL RESEARCH
- The multifaceted roles of PARP1 in DNA repair and chromatin remodelling
- (2017) Arnab Ray Chaudhuri et al. NATURE REVIEWS MOLECULAR CELL BIOLOGY
- Treatment of nonalcoholic fatty liver disease: role of AMPK
- (2016) Brennan K. Smith et al. AMERICAN JOURNAL OF PHYSIOLOGY-ENDOCRINOLOGY AND METABOLISM
- New Insights into the Roles of NAD+-Poly(ADP-ribose) Metabolism and Poly(ADP-ribose) Glycohydrolase
- (2016) Sei-ichi Tanuma et al. CURRENT PROTEIN & PEPTIDE SCIENCE
- Elafibranor, an Agonist of the Peroxisome Proliferator−Activated Receptor−α and −δ, Induces Resolution of Nonalcoholic Steatohepatitis Without Fibrosis Worsening
- (2016) Vlad Ratziu et al. GASTROENTEROLOGY
- Therapeutic potential of nicotinamide adenine dinucleotide for nonalcoholic fatty liver disease
- (2016) Philippe Gual et al. HEPATOLOGY
- Silibinin Regulates Lipid Metabolism and Differentiation in Functional Human Adipocytes
- (2016) Ignazio Barbagallo et al. Frontiers in Pharmacology
- Lifestyle changes for the treatment of nonalcoholic fatty liver disease: a review of observational studies and intervention trials
- (2016) Shira Zelber-Sagi et al. Therapeutic Advances in Gastroenterology
- NAD+ Metabolism and the Control of Energy Homeostasis: A Balancing Act between Mitochondria and the Nucleus
- (2015) Carles Cantó et al. Cell Metabolism
- The Pros and the Cons for the Use of Silybin-Rich Oral Formulations in Treatment of Liver Damage (NAFLD in Particular)
- (2015) Natalia Rosso et al. CURRENT MEDICINAL CHEMISTRY
- Nonalcoholic fatty liver disease: A precursor of the metabolic syndrome
- (2015) Amedeo Lonardo et al. DIGESTIVE AND LIVER DISEASE
- Nonalcoholic Steatohepatitis Is the Second Leading Etiology of Liver Disease Among Adults Awaiting Liver Transplantation in the United States
- (2015) Robert J. Wong et al. GASTROENTEROLOGY
- Eliciting the mitochondrial unfolded protein response by nicotinamide adenine dinucleotide repletion reverses fatty liver disease in mice
- (2015) Karim Gariani et al. HEPATOLOGY
- Natural antioxidants for non-alcoholic fatty liver disease: molecular targets and clinical perspectives
- (2015) Federico Salomone et al. LIVER INTERNATIONAL
- Transcriptional regulation of hepatic lipogenesis
- (2015) Yuhui Wang et al. NATURE REVIEWS MOLECULAR CELL BIOLOGY
- Troxerutin improves hepatic lipid homeostasis by restoring NAD+-depletion-mediated dysfunction of lipin 1 signaling in high-fat diet-treated mice
- (2014) Zi-Feng Zhang et al. BIOCHEMICAL PHARMACOLOGY
- State of the art
- (2014) Michelle Pearlman et al. CURRENT OPINION IN GASTROENTEROLOGY
- A Redox-resistant Sirtuin-1 Mutant Protects against Hepatic Metabolic and Oxidant Stress
- (2014) Di Shao et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Hepatoprotective effects of the dual peroxisome proliferator-activated receptor alpha/delta agonist, GFT505, in rodent models of nonalcoholic fatty liver disease/nonalcoholic steatohepatitis
- (2013) Bart Staels et al. HEPATOLOGY
- Reduced adiponectin signaling due to weight gain results in nonalcoholic steatohepatitis through impaired mitochondrial biogenesis
- (2013) Priya Handa et al. HEPATOLOGY
- Silibinin ameliorates steatosis and insulin resistance during non-alcoholic fatty liver disease development partly through targeting IRS-1/PI3K/Akt pathway
- (2013) Yongxiang Zhang et al. INTERNATIONAL IMMUNOPHARMACOLOGY
- Hepatic menin recruits SIRT1 to control liver steatosis through histone deacetylation
- (2013) Yanan Cao et al. JOURNAL OF HEPATOLOGY
- Lipid-Induced Toxicity Stimulates Hepatocytes to Release Angiogenic Microparticles That Require Vanin-1 for Uptake by Endothelial Cells
- (2013) D. Povero et al. Science Signaling
- Silybin combined with phosphatidylcholine and vitamin E in patients with nonalcoholic fatty liver disease: A randomized controlled trial
- (2012) Carmela Loguercio et al. FREE RADICAL BIOLOGY AND MEDICINE
- Sirtuins mediate mammalian metabolic responses to nutrient availability
- (2012) Angeliki Chalkiadaki et al. Nature Reviews Endocrinology
- Silibinin modulates lipid homeostasis and inhibits nuclear factor kappa B activation in experimental nonalcoholic steatohepatitis
- (2012) Federico Salamone et al. Translational Research
- Systematic review: the epidemiology and natural history of non-alcoholic fatty liver disease and non-alcoholic steatohepatitis in adults
- (2011) G. Vernon et al. ALIMENTARY PHARMACOLOGY & THERAPEUTICS
- Effect of silybin on high-fat-induced fatty liver in rats
- (2011) Jiayin Yao et al. BRAZILIAN JOURNAL OF MEDICAL AND BIOLOGICAL RESEARCH
- Silibinin improves hepatic and myocardial injury in mice with nonalcoholic steatohepatitis
- (2011) Federico Salamone et al. DIGESTIVE AND LIVER DISEASE
- Silybin and the liver: From basic research to clinical practice
- (2011) Carmela Loguercio WORLD JOURNAL OF GASTROENTEROLOGY
- Lack of SIRT1 (Mammalian Sirtuin 1) Activity Leads to Liver Steatosis in the SIRT1+/−Mice: A Role of Lipid Mobilization and Inflammation
- (2010) Fen Xu et al. ENDOCRINOLOGY
- Evolution of inflammation in nonalcoholic fatty liver disease: The multiple parallel hits hypothesis
- (2010) Herbert Tilg et al. HEPATOLOGY
- Antioxidant and Hepatoprotective Effects of Silibinin in a Rat Model of Nonalcoholic Steatohepatitis
- (2009) Yara Haddad et al. Evidence-based Complementary and Alternative Medicine
- Silybin, a component of sylimarin, exerts anti-inflammatory and anti-fibrogenic effects on human hepatic stellate cells
- (2009) Marco Trappoliere et al. JOURNAL OF HEPATOLOGY
- A Silybin-Phospholipid Complex Prevents Mitochondrial Dysfunction in a Rodent Model of Nonalcoholic Steatohepatitis
- (2009) G. Serviddio et al. JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS
- Specific SIRT1 Activation Mimics Low Energy Levels and Protects against Diet-Induced Metabolic Disorders by Enhancing Fat Oxidation
- (2008) Jérôme N. Feige et al. Cell Metabolism
- SIRT1 Regulates Hepatocyte Lipid Metabolism through Activating AMP-activated Protein Kinase
- (2008) Xiuyun Hou et al. JOURNAL OF BIOLOGICAL CHEMISTRY
Become a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get StartedAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started